Search research articles
Contact Us
Filters
Showing results (111-120 of 140) with videos related to
Page
of 14
Sort By:
Indian Journal of Nephrology
|
April 7, 2016
ABO-incompatible renal transplantation in developing world - crossing the immunological (and mental) barrier
P K Jha, S B Bansal, S K Sethi, et al.
Hepatology (Baltimore, Md.)
|
May 13, 2009
Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation
Feng Hong, Ana Tuyama, Ting Fang Lee, et al.
Digestive Diseases and Sciences
|
June 22, 2010
Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen I expression
Brian D Radbill, Ritu Gupta, Maria Celeste M Ramirez, et al.
Journal of Leukocyte Biology
|
December 18, 2016
Frontline Science: HIV infection of Kupffer cells results in an amplified proinflammatory response to LPS
Arevik Mosoian, Lumin Zhang, Feng Hong, et al.
JHEP Reports : Innovation in Hepatology
|
March 20, 2023
Environmental exposures are important risk factors for advanced liver fibrosis in African American adults
Ning Ma, Rowena Yip, Sara Lewis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 7, 2024
Clinicopathological Profile and Survival Outcomes in Patients with Localised Extremity Synovial Sarcomas
J Sharma, S V S Deo, S Kumar, et al.
Journal of Environmental Sciences (China)
|
April 17, 2025
Mixture analysis of associations between environmental and workplace toxins and liver damage and telomere length, stratified by race/ethnicity
Ning Ma, Rowena Yip, Mark Woodward, et al.
JHEP Reports : Innovation in Hepatology
|
June 30, 2026
Sexual dimorphism in the association of circulating TAM receptors-ligands with MASLD-related fibrosis
Yiwei Zhu, Neha Gupta, Bruno Cogliati, et al.
The Lancet. HIV
|
July 7, 2024
Steatotic liver disease and HIV: an agenda for 2030
Juan M Pericàs, Anish K Arora, Carlotta Riebensahm, et al.
Lancet (London, England)
|
November 16, 2019
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A Harrison, Mustafa R Bashir, Cynthia D Guy, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 140) with videos related to
Sort By:
Page
of 14
Indian Journal of Nephrology
|
April 7, 2016
ABO-incompatible renal transplantation in developing world - crossing the immunological (and mental) barrier
P K Jha, S B Bansal, S K Sethi, et al.
Hepatology (Baltimore, Md.)
|
May 13, 2009
Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation
Feng Hong, Ana Tuyama, Ting Fang Lee, et al.
Digestive Diseases and Sciences
|
June 22, 2010
Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen I expression
Brian D Radbill, Ritu Gupta, Maria Celeste M Ramirez, et al.
Journal of Leukocyte Biology
|
December 18, 2016
Frontline Science: HIV infection of Kupffer cells results in an amplified proinflammatory response to LPS
Arevik Mosoian, Lumin Zhang, Feng Hong, et al.
JHEP Reports : Innovation in Hepatology
|
March 20, 2023
Environmental exposures are important risk factors for advanced liver fibrosis in African American adults
Ning Ma, Rowena Yip, Sara Lewis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 7, 2024
Clinicopathological Profile and Survival Outcomes in Patients with Localised Extremity Synovial Sarcomas
J Sharma, S V S Deo, S Kumar, et al.
Journal of Environmental Sciences (China)
|
April 17, 2025
Mixture analysis of associations between environmental and workplace toxins and liver damage and telomere length, stratified by race/ethnicity
Ning Ma, Rowena Yip, Mark Woodward, et al.
JHEP Reports : Innovation in Hepatology
|
June 30, 2026
Sexual dimorphism in the association of circulating TAM receptors-ligands with MASLD-related fibrosis
Yiwei Zhu, Neha Gupta, Bruno Cogliati, et al.
The Lancet. HIV
|
July 7, 2024
Steatotic liver disease and HIV: an agenda for 2030
Juan M Pericàs, Anish K Arora, Carlotta Riebensahm, et al.
Lancet (London, England)
|
November 16, 2019
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A Harrison, Mustafa R Bashir, Cynthia D Guy, et al.
Page
of 14